实用中西医结合临床2024,Vol.24Issue(5) :6-9,34.DOI:10.13638/j.issn.1671-4040.2024.05.002

基于"脑-肠轴"理论探讨疏肝理脾汤联合穴位埋线对肝郁脾虚型溃疡性结肠炎的疗效

Exploring the Therapeutic Efficacy of Shuganlipi Decoction Combined with Acupoint Catgut Embedding Liver Depression and Spleen Deficiency Type Ulcerative Colitis Based on the Brain-Gut Axis

章钰川 余绪超 肖慧荣 吴娜 涂艳琴
实用中西医结合临床2024,Vol.24Issue(5) :6-9,34.DOI:10.13638/j.issn.1671-4040.2024.05.002

基于"脑-肠轴"理论探讨疏肝理脾汤联合穴位埋线对肝郁脾虚型溃疡性结肠炎的疗效

Exploring the Therapeutic Efficacy of Shuganlipi Decoction Combined with Acupoint Catgut Embedding Liver Depression and Spleen Deficiency Type Ulcerative Colitis Based on the Brain-Gut Axis

章钰川 1余绪超 2肖慧荣 2吴娜 2涂艳琴1
扫码查看

作者信息

  • 1. 江西中医药大学 南昌 330004
  • 2. 江西中医药大学附属医院 南昌 330006
  • 折叠

摘要

目的 从"脑-肠轴"角度分析疏肝理脾汤联合穴位埋线对肝郁脾虚型溃疡性结肠炎(UC)的疗效.方法 选取 2020 年 1 月至 2023 年 1 月在江西中医药大学附属医院肛肠科住院的 80 例UC患者.按照随机数字表法分为观察组 40 例(予疏肝理脾汤口服以及穴位埋线治疗)与对照组 40 例(予美沙拉嗪肠溶片口服),观察比较两组治疗前后临床疗效、黏膜愈合率、中医证候评分、改良Mayo评分、脑肠肽指标.结果 治疗后,观察组临床疗效、黏膜愈合率优于对照组(P<0.05);两组中医证候评分、改良Mayo评分均较前显著降低,且观察组优于对照组(P<0.01);观察组血清 5-羟色胺、P物质均较前显著降低、血管活性肠肽较前升高,且观察组优于对照组(P<0.01).两组均未发生明显不良反应.结论 疏肝理脾汤联合穴位埋线治疗UC临床效果显著,能有效调节患者脑肠肽指标,减轻黏膜病变程度,提高生活质量.

Abstract

Objective Analyzing the therapeutic effic acy of Shuganlipi Decoction combined with acupoint catgut embedding on Liver Depression and Spleen Deficiency type ulcerative colitis from the perspective of brain gut axis..Methods 80 UC patients admitted to the Department of Gastroenterology at the Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine from January 2020 to January 2023 were selected for the study.Patients were randomly divided into an observation group of 40 cases(treated with Shuganlipi Decoction orally and acupoint catgut embedding)and a control group of 40 cases(treated with Mesalazine Slow Release Tablets orally).Clinical efficacy,mucosal healing rate,traditional Chinese medicine syndrome score,modified Mayo score,and brain-gut peptide indicators were observed and compared before and after treatment in both groups.Results After treatment,the clinical efficacy and mucosal healing rate in the observation group were higher than those in the control group(P<0.05).Both groups showed a significant reduction in traditional Chinese medicine syndrome scores and modified Mayo scores after treatment and the observation group performed better than the control group(P<0.01).The serum levels of 5-HT and SP in the observation group exhibited a pronounced decrease compared to before treatment,while VIP levels increased significantly.The observation group performed better than the control group(P<0.01).No adverse reactions were observed in either group.Conclusion The combination of Shuganlipi Decoction and acupoint catgut embedding has a significant therapeutic effect,effectively regulating the brain-gut peptide levels in patients,reducing mucosal lesions,and enhancing the quality of life.

关键词

溃疡性结肠炎/疏肝理脾汤/穴位埋线/脑-肠轴

Key words

Ulcerative colitis/Shuganlipi Decoction/Acupoint catgut embedding/Brain-Gut Axis

引用本文复制引用

基金项目

国家自然科学基金(82160903)

江西省中医药科技计划重点项目(2023)(2023Z005)

江西省中医药局科技项目(2023)(2023A0128)

出版年

2024
实用中西医结合临床
江西省中医药研究院,江西省中西医结合学会

实用中西医结合临床

影响因子:0.522
ISSN:1671-4040
参考文献量18
段落导航相关论文